Clinical Trial: An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: The purpose of this study is to determine the safety of topical FP1198 for the treatment of moderate to severe cyclic breast pain (cyclic mastalgia) and to examine the clinical activity of FP1198.

Detailed Summary:
Sponsor: FemmePharma Global Healthcare, Inc.

Current Primary Outcome: Reduction in breast pain [ Time Frame: six months ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: FemmePharma Global Healthcare, Inc.

Dates:
Date Received: April 13, 2010
Date Started: June 2010
Date Completion:
Last Updated: October 25, 2011
Last Verified: October 2011